These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4329806)

  • 1. Mechanisms responsible for the hyperglycemia produced by the dibutyryl derivative of cyclic 3',5'-adenosine monophosphate.
    Altszuler N; Rathgeb I; Steele R
    Biochem Pharmacol; 1971 Oct; 20(10):2813-9. PubMed ID: 4329806
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of cyclic 3',5'-adenosine monophosphate and dibutyryl cyclic 3',5'-adenosine monophosphate on basal and stimulated thyroid function.
    Burke G
    J Clin Endocrinol Metab; 1968 Dec; 28(12):1816-23. PubMed ID: 4301766
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic evaluation of sexual dimorphism. II. Effects of epinephrine and dibutyryl 3',5' cyclic AMP on glucose oxidation.
    Floridi A; Lindsay RH
    Life Sci I; 1971 Jul; 10(13):761-5. PubMed ID: 4335201
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucose metabolism and plasma insulin level during epinephrine infusion in the dog.
    Altszuler N; Steele R; Rathgeb I; De Bodo RC
    Am J Physiol; 1967 Mar; 212(3):677-82. PubMed ID: 6020543
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of dibutyryl cyclic adenosine 3',5'-monophosphate on glucose transport and metabolism in rat adipose tissue.
    Schimmel RJ; Goodman HM
    Biochim Biophys Acta; 1971 Jun; 239(1):9-15. PubMed ID: 4328175
    [No Abstract]   [Full Text] [Related]  

  • 6. Increase in plasma glucose concentration after intracerebroventricular injection of N,O'-dibutyryl cyclic adenosine 3',5'-monophosphate.
    Iguchi A; Gotoh M; Matsunaga H; Ohuchi M; Nomura T; Sakamoto N
    Endocrinology; 1986 Jul; 119(1):125-9. PubMed ID: 2873022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent biological effects of adenosine and dibutyryl adenosine 3',5'-monophosphate on the isolated fat cell.
    Solomon SS; Brush JS; Kitabchi AE
    Science; 1970 Jul; 169(3943):387-8. PubMed ID: 4317897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonistic actions between dibutyryl adenosine-3',5'-cyclic monophosphate and insulin on the metabolism of the surviving rat diaphragm.
    Chambaut AM; Eboué-Bonis D; Hanoune J; Clauser H
    Biochem Biophys Res Commun; 1969 Feb; 34(3):283-90. PubMed ID: 4304154
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal effects of adenosine 3',5'-cyclic monophosphate and dibutyryl adenosine 3',5'-cyclic monophosphate. Evidence for a role for adenosine 3',5'-cyclic monophosphate in the regulation of proximal tubular sodium reabsorption.
    Gill JR; Casper AG
    J Clin Invest; 1971 Jun; 50(6):1231-40. PubMed ID: 4326154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of cyclic adenosine-3',5'-monophosphate (3',5'-AMP) and its dibutyryl derivative (DBA) on lipolysis, glycogenolysis and corticosterone synthesis].
    Bieck P; Stock K; Westermann E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(3):387-405. PubMed ID: 4306981
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the correlation between hyperglycemia and hyperkalemia. II. Effects of cyclic 3',5'-AMP and theophylline on dogs].
    Nishiue T
    Nihon Yakurigaku Zasshi; 1967 Jul; 63(4):290-301. PubMed ID: 6070469
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic effects of epinephrine, dibutyryl cyclic AMP, and glucagon infused intravenously into normal dogs.
    Altszuler N; Morrison A; Steele R; Bjerknes C
    Ann N Y Acad Sci; 1971 Dec; 185():101-7. PubMed ID: 4330483
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of calcium (Ca++) in TSH and dibutyryl 3'5' cyclic AMP stimulation of thyroid glucose oxidation and phospholipid synthesis.
    Zor U; Lowe IP; Bloom G; Field JB
    Biochem Biophys Res Commun; 1968 Nov; 33(4):649-58. PubMed ID: 4301489
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function.
    Salzman EW; Levine L
    J Clin Invest; 1971 Jan; 50(1):131-41. PubMed ID: 4322665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen metabolism of the thyroid.
    Ahn CS
    Endocrinology; 1971 Jun; 88(6):1341-8. PubMed ID: 4324678
    [No Abstract]   [Full Text] [Related]  

  • 16. Pineal gland: dibutyryl cyclic adenosine monophosphate stimulation of labeled melatonin production.
    Klein DC; Berg GR; Weller J; Glinsmann W
    Science; 1970 Mar; 167(3926):1738-40. PubMed ID: 4313580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of thyroid metabolism by thyrotropin, cyclic 3':5'-AMP, dibutyryl cyclic 3':5'-AMP and prostaglandin E1.
    Rodesch F; Neve P; Willems C; Dumont JE
    Eur J Biochem; 1969 Mar; 8(1):26-32. PubMed ID: 4181076
    [No Abstract]   [Full Text] [Related]  

  • 18. Adrenal corticosteroid involvement in the control of liver glycogen phosphorylase activity.
    Schaeffer LD; Chenoweth M; Dunn A
    Biochim Biophys Acta; 1969 Nov; 192(2):292-303. PubMed ID: 4313074
    [No Abstract]   [Full Text] [Related]  

  • 19. Different effects of exogenous cyclic adenosine monophosphate and its dibutryl derivative on plasma growth hormone, glucose, insulin and cortisol.
    Vanderschueren-Lodeweyckx M; Proesmans W; Eggermont E; Eeckels R
    Acta Endocrinol (Copenh); 1976 Sep; 83(1):15-25. PubMed ID: 183441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of catecholamines and dibutyryl-cyclic-AMP on glucose turnover, plasma free fatty acids, and insulin in dogs treated with methylprednisolone.
    Issekutz B; Borkow I
    Can J Physiol Pharmacol; 1972 Oct; 50(10):999-1006. PubMed ID: 4344356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.